Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion type Assertion NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_head.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion description "[Calpain-10 (CAPN10) gene was the first candidate gene of T2D identified through genome-wide linkage and positional cloning, but few works have focused on the relationship of CAPN10 with impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) in EH patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_provenance.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion evidence source_evidence_literature NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_provenance.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion SIO_000772 20406624 NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_provenance.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion wasDerivedFrom befree-2016 NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_provenance.
- NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_assertion wasGeneratedBy ECO_0000203 NP807168.RAy6wsljHW3Kkw2fsAC8y3_bOXkywrqo6RzUay7cFHQvw130_provenance.